Molecular Devices and Caliper Technologies Settle Patent Infringement Suit

Molecular Devices and Caliper Technologies Settle Patent Infringement Suit 


SUNNYVALE, Calif., Nov. 4  /PRNewswire-FirstCall/ -- Molecular Devices
Corporation  today announced it has settled the patent infringement lawsuit
filed against Molecular Devices by Caliper Technologies Corp. in 2002 involving
Molecular Devices' IMAP products.  In connection with the settlement, Molecular
Devices and Caliper have entered into a nonexclusive license agreement pursuant
to which Molecular Devices has agreed to pay to Caliper a one-time licensing fee
as well as royalties based on future sales of IMAP products.  Financial details
of the settlement were not disclosed.

"We are pleased to have concluded this matter on terms that will not be material
to our business so we can focus our resources on developing and marketing
products that will address the needs of our customers and facilitate growth in
our business," stated Joseph D. Keegan, Ph.D., Molecular Devices' President and
Chief Executive Officer.

About Molecular Devices Corporation

Molecular Devices Corporation is a leading supplier of high-performance
bioanalytical measurement systems that accelerate and improve drug discovery and
other life sciences research.  The Company's systems and consumables enable
pharmaceutical and biotechnology companies to leverage advances in genomics,
proteomics and combinatorial chemistry by facilitating the high-throughput and
cost-effective identification and evaluation of drug candidates.  The Company's
solutions are based on its advanced core technologies that integrate its
expertise in engineering, molecular and cell biology and chemistry.  Molecular
Devices enables its customers to improve research productivity and
effectiveness, which ultimately accelerates the complex process of discovering
and developing new drugs.

This press release contains "forward-looking" statements, including statements
related to the impact of the settlement on our business and future growth of
this business.  Any statements contained in this press release that are not
statements of historical fact may be deemed to be forward-looking statements. 
Words such as "believes," "anticipates," "plans," "expects," "will," and similar
expressions are intended to identify forward-looking statements.  There are a
number of important factors that could cause the results of Molecular Devices
Corporation to differ materially from those indicated by these forward-looking
statements, including, among others, risks detailed from time to time in the
Company's SEC reports, including its Annual Report on Form 10-K for the year
ended December 31, 2002 and its quarterly report on Form 10-Q for the quarter
ended September 30, 2003.  Molecular Devices Corporation does not undertake any
obligation to update forward-looking statements 

DATASOURCE: Molecular Devices Corporation



CONTACT:  Tim Harkness of Molecular Devices Corporation, [phone]



Web site:  http://www.moleculardevices.com/ 

Copyright